晚期系统性硬化症中新发间质性肺病的特征分析
该队列研究纳入加拿大硬皮病研究组2004至2020年969例无 prevalent ILD 的系统性硬化症患者,中位随访2.4年,199例(21%)新发间质性肺病;晚期系统性硬化症(病程>7年)的间质性肺病发病率低于早期(相对风险0.68,95%CI 0.51-0.92),但肺病严重程度与进展率相似,结论认为长期系统性硬化症仍需继续监测间质性肺病。
要点
- 969例系统性硬化症患者中199例(21%)新发间质性肺病,中位随访2.4年。
- 晚期系统性硬化症(病程>7年)间质性肺病发病率低于早期(相对风险0.68,95%CI 0.51-0.92)。
- 晚期与早期起病的间质性肺病在肺功能严重程度和进展率上相似(风险比1.11,95%CI 0.58-2.10)。
核心结论
- 间质性肺病可发生于晚期系统性硬化症,其危险因素和进展率与早期起病的系统性硬化症间质性肺病有重叠,长期系统性硬化症应继续监测间质性肺病,监测频率和方式尚待明确。
研究设计与样本
- 研究纳入加拿大硬皮病研究组队列2004至2020年无 prevalent 间质性肺病的系统性硬化症患者,按距首个非雷诺现象表现病程>7年(晚期)和≤7年(早期)分组,比较间质性肺病(高分辨率计算机断层扫描诊断)的发病率和危险因素,采用Kaplan-Meier和多变量Cox模型比较间质性肺病进展风险。
主要发现
- 969例患者中199例(21%)新发间质性肺病,中位随访2.4年(四分位距1.2-4.3年)。
- 晚期系统性硬化症的间质性肺病发病率为3.7/100人年,低于早期系统性硬化症(相对风险0.68,95%CI 0.51-0.92)。
- 新发间质性肺病的危险因素包括男性、弥漫型、肌炎、抗拓扑异构酶I抗体和较高的C反应蛋白水平;晚期起病间质性肺病患者白种人比例较低,关节炎和抗RNA聚合酶III抗体比例较高。
- 晚期与早期起病系统性硬化症间质性肺病的肺病严重程度相似(用力肺活量分别为88%和87%,一氧化碳弥散量分别为64%和62%)。
- 晚期与早期起病系统性硬化症间质性肺病的进展率相似(log rank P=0.8,风险比1.11,95%CI 0.58-2.10)。
临床怎么用
- 作者认为,长期系统性硬化症应继续监测间质性肺病,但监测的频率和方式尚待明确。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Interstitial lung disease (ILD) is a common and potentially lethal complication of systemic sclerosis (SSc). Screening by high-resolution computed tomography (HRCT) is recommended in all patients with risk factors, including early disease. Little is known on late presentations of ILD. This study aimed to characterize the incidence, risk factors, and outcomes of late-onset SSc-ILD. METHODS: Study participants enrolled in the Canadian Scleroderma Research Group cohort from 2004 to 2020 without prevalent ILD were included. Incidence and risk factors for ILD (on HRCT) were compared according to disease duration above (late) and below (earlier) seven years from the first non-Raynaud manifestation. Risk of ILD progression was compared using Kaplan-Meier and multivariable Cox models. RESULTS: Overall, 199 (21%) of 969 patients developed incident ILD over a median of 2.4 (interquartile range 1.2-4.3) years. The incidence rate in late SSc (3.7/100 person-years) was lower than in earlier SSc (relative risk 0.68, 95% confidence interval [CI] 0.51-0.92). Risk factors for incident ILD included male sex, diffuse subtype, myositis, antitopoisomerase I autoantibodies, and higher C-reactive protein levels. Patients with late-onset ILD were also less frequently White and more frequently had arthritis and anti-RNA-polymerase III autoantibodies. Lung disease severity was similar between late- and earlier-onset SSc-ILD (forced vital capacity 88% and 87%, diffusion capacity of the lungs for carbon monoxide 64% and 62%, respectively). Progression rates were also similar between late- and earlier-onset SSc-ILD (log rank P = 0.8, hazard ratio 1.11, 95% CI 0.58-2.10). CONCLUSION: ILD can present in late SSc. Risk factors and progression rates overlapped with earlier-onset SSc-ILD. Surveillance for ILD should continue in longstanding SSc. Frequency and modality of monitoring remain to be defined.
引用
- Hoa S, Berger C, Lahmek N, et al. Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis. Arthritis Rheumatol. 2025. PMID: 39492683. doi:10.1002/art.43051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。